Cytochrome P450-based gene therapy for cancer treatment: From concept to the clinic

Current Drug Metabolism

Volumn 3, Issue 6, 2002, Pages 609-622

  Jounaidi, Youssef ^a  

^a Boston University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 (1 AZIRIDINYL) 2,4 DINITROBENZAMIDE; ANILINE MUSTARD; ANTINEOPLASTIC AGENT; CHLORMETHINE DERIVATIVE; CHLOROACETALDEHYDE; CYCLOPHOSPHAMIDE; CYTOCHROME P450; CYTOCHROME P450 2B1; CYTOSINE DEAMINASE; DACARBAZINE; DEXAMETHASONE; ETOPOSIDE; GANCICLOVIR; IFOSFAMIDE; KETOCONAZOLE; LIVER ENZYME; NEMORUBICIN; NITROREDUCTASE; OXAZAPHOSPHORINE DERIVATIVE; PHENOBARBITAL; PREDNISONE; PROCARBAZINE; PRODRUG; PROPYLTHIOURACIL; RIFAMPICIN; TEGAFUR; THIAMAZOLE; THYMIDINE KINASE; TROLEANDOMYCIN; UNINDEXED DRUG;

BYSTANDER EFFECT; CANCER; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG ACTIVATION; DRUG BIOAVAILABILITY; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME THERAPY; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNE SYSTEM; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RAT; REVIEW; SIDE EFFECT; SITE DIRECTED MUTAGENESIS; SUICIDE GENE THERAPY; VIRUS REPLICATION;

ANIMALS; CLINICAL TRIALS; CYTOCHROME P-450 ENZYME SYSTEM; DRUG DELIVERY SYSTEMS; GENE THERAPY; HUMANS; NEOPLASMS; PRODRUGS;

EID: 0036890432     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389200023337027     Document Type: Review

References (134)

1. Aghi, M.; Hochberg, F. and Breakefield, X.O. (2000) J. Gene Med., 2(3), 148-164.
2. Moolten, F.L. (1986) Cancer Res., 46(10), 5276-5281.
3. Philpott, G.W.; Shearer, W.T.; Bower, R.J. and Parker, C.W. (1973) J. Immunol., 111(3), 921-929.
4. Fleming, R.A. (1997) Pharmacotherapy, 17(5 Pt 2), 146S-154S.
5. Gilman, A. (1963) Am. J. Surg., 105, 574-578.
6. Goodman, L.S.; Wintrobe, M.M.; Dameshek, W.; Goodman, M.J.; Gilman, A. and McLennan, M.T. (1984) JAMA, 251(17), 2255-2261.
7. Connors, T.A. and Whisson, M.E. (1966) Nature, 210(38), 866-867.
8. Cobb, L.M.; Connors, T.A.; Elson, L.A.; Khan, A.H.; Mitchley, B.C.; Ross, W.C. and Whisson, M.E. (1969) Biochem. Pharmacol., 18(6), 1519-1527.
9. Webley, S.D.; Francis, R.J.; Pedley, R.B.; Sharma, S.K.; Begent, R.H.; Hartley, J.A. and Hochhauser, D. (2001) Br. J. Cancer, 84(12), 1671-1676.
10. Brock, N. (1989) Cancer Res., 49(1), 1-7.
11. Bielicki, L.; Voelcker, G. and Hohorst, H.J. (1984) J. Cancer Res. Clin. Oncol., 107(3), 195-198.
12. Smith, G.; Harrison, D.J.; East, N.; Rae, F.; Wolf, H. and Wolf, C.R. (1993) Br. J. Cancer, 68(1), 57-63.
13. Huang, Z.; Fasco, M.J.; Figge, H.L.; Keyomarsi, K. and Kaminsky, L.S. (1996) Drug Metab. Dispos., 24(8), 899-905.
14. Nakajima, T.; Wang, R.S.; Nimura, Y.; Pin, Y.M.; He, M.; Vainio, H.; Murayama, N.; Aoyama, T. and Iida, F. (1996) Carcinogenesis, 17(7), 1477-1481.
15. Murray, G.I.; McFadyen, M.C.; Mitchell, R.T.; Cheung, Y.L.; Kerr, A.C. and Melvin, W.T. (1999) Br. J. Cancer, 79(11-12), 1836-1842.
16. Sladek, N.E. (1988) Pharmacol. Ther., 37(3), 301-355.
17. Clarke, L. and Waxman, D.J. (1989) Cancer Res., 49(9), 2344-2350.
18. Chang, T.K.H.; Weber, G.F.; Crespi, C.L. and Waxman, D.J. (1993) Cancer Res., 53(23), 5629-5637.
19. Weber, G.F. and Waxman, D.J. (1993) Biochem. Pharmacol., 45(8), 1685-1694.
20. Demetri, G.D. (1996) Semin. Oncol., 23(3 Suppl. 6), 22-26.
21. Overmoyer, B.A. (1996) Semin. Oncol., 23(3 Suppl. 6), 38-41.
22. Shimada, T.; Yamazaki, H.; Mimura, M.; Inui, Y. and Guengerich, F.P. (1994) J. Pharmacol. Exp. Ther., 270(1), 414-423.
23. Furuya, H.; Meyer, U.A.; Gelboin, H.V. and Gonzalez, F.J. (1991) Mol. Pharmacol., 40(3), 375-382.
24. Chang, T.K.; Yu, L.; Goldstein, J.A. and Waxman, D.J. (1997) Pharmacogenetics, 7(3), 211-221.
25. Jounaidi, Y.; Hecht, J.E.D. and Waxman, D.J. (1998) Cancer Res., 58(19), 4391-4401.
26. Goldstein, J.A.; Faletto, M.B.; Romkes-Sparks, M.; Sullivan, T.; Kitareewan, S.; Raucy, J.L.; Lasker, J.M. and Ghanayem, B.I. (1994) Biochemistry, 33(7), 1743-1752.
27. Faber, O.K.; Mouridsen, H.T. and Skovsted, L. (1975) Br. J. Clin. Pharmacol., 2(3), 281-285.
28. Dechant, K.L.; Brogden, R.N.; Pilkington, T. and Faulds, D. (1991) Drugs, 42(3), 428-467.
29. Kaijser, G.P.; Beijnen, J.H.; Jeunink, E.L.; Bult, A.; Keizer, H.J.; de Kraker, J. and Underberg, W.J. (1993) J. Chromatogr., 614(2), 253-259.
30. Bruggemann, S.K.; Kisro, J. and Wagner, T. (1997) Cancer Res., 57(13), 2676-2680.
31. Borner, K.; Kisro, J.; Bruggemann, S.K.; Hagenah, W.; Peters, S.O. and Wagner, T. (2000) Drug Metab. Dispos., 28(5), 573-576.
32. Brade, W.; Seeber, S. and Herdrich, K. (1986) Cancer Chemother. Pharmacol., 18(Suppl. 2), S1-9.
33. Bramwell, V.H.; Mouridsen, H.T.; Santoro, A.; Blackledge, G.; Somers, R.; Verwey, J.; Dombernowsky, P.; Onsrud, M.; Thomas, D. and Sylvester, R. (1987) Eur. J. Cancer Clin. Oncol., 23(3), 311-321.
34. Teicher, B.A. and Frei, E. 3rd (1988) Cancer Chemother. Pharmacol., 21(4), 292-298.
35. Frei, E. 3rd.; Teicher, B.A.; Holden, S.A.; Cathcart, K.N. and Wang, Y.Y. (1988) Cancer Res., 48(22), 6417-6423.
36. Ayash, L.J.; Wright, J.E.; Tretyakov, O.; Gonin, R.; Elias, A.; Wheeler, C.; Eder, J.P.; Rosowsky, A.; Antman, K. and Frei, E.I. (1992) J. Clin. Oncol., 10(6), 995-1000.
37. Thigpen, T. (1991) Gynecol. Oncol., 42(3), 191-192.
38. Davidoff, A.N. and Mendelow, B.V. (1993) Exp. Hematol., 21(7), 922-927.
39. Lee, J.H.; Park, J.H. and Yang, M.H. (1997) J. Korean Med. Sci., 12(3), 185-189.
40. Karle, P.; Renner, M.; Salmons, B. and Gunzburg, W.H. (2001) Cancer Gene Ther., 8(3), 220-230.
41. Schwartz, P.S. and Waxman, D.J. (2001) Mol. Pharmacol., 60(6), 1268-1279.
42. Wei, M.X.; Tamiya, T.; Chase, M.; Boviatsis, E.J.; Chang, T.K.H.; Kowall, N.W.; Hochberg, F.H.; Waxman, D.J.; Breakefield, X.O. and Chiocca, E.A. (1994) Hum. Gene Ther., 5(8), 969-978.
43. Chen, L. and Waxman, D.J. (1995) Cancer Research., 55(3), 581-589.
44. Manome, Y.; Wen, P.Y.; Chen, L.; Tanaka, T.; Dong, Y.; Yamazoe, M.; Hirshowitz, A.; Kufe, D.W. and Fine, H.A. (1996) Gene Therapy, 3(6), 513-520.
45. Chen, L.; Waxman, D.J.; Chen, D. and Kufe, D.W. (1996) Cancer Res., 56(6), 1331-1340.
46. Yu, L.J.; Matias, J.; Scudiero, D.A.; Hite, K.M.; Monks, A.; Sausville, E.A. and Waxman, D.J. (2001) Drug Metab. Dispos., 29(3), 304-312.
47. Chen, L.; Yu, L.J. and Waxman, D.J. (1997) Cancer Res., 57(21), 4830-4837.
48. Chen, L.; Chen, D.; Manome, Y.; Dong, Y.; Fine, H.A. and Kufe, D.W. (1995) J. Clin. Invest., 96(6), 2775-2782.
49. Black, M.E.; Newcomb, T.G.; Wilson, H.M. and Loeb, L.A. (1996) Proc. Natl. Acad. Sci. USA, 93(8), 3525-3529.
50. Huang, Z.; Roy, P. and Waxman, D.J. (2000) Biochem. Pharmacol., 59(8), 961-972.
51. Domanski, T.L. and Halpert, J.R. (2001) Curr. Drug Metab., 2(2), 117-137.
52. Williams, P.A.; Cosme, J.; Sridhar, V.; Johnson, E.F. and McRee, D.E. (2000) Mol. Cell., 5(1), 121-131.
53. Pichard, L.; Fabre, I.; Fabre, G.; Domergue, J.; Saint Aubert, B.; Mourad, G. and Maurel, P. (1990) Drug Metab. Dispos., 18(5), 595-606.
54. Jao, J.Y.; Jusko, W.J. and Cohen, J.L. (1972) Cancer Res., 32(12), 2761-2764.
55. Faber, O.K.; Mouridsen, H.T. and Skovsted, L. (1974) Acta Pharmacol. Toxicol., 35(3), 195-200.
56. Yule, S.M.; Boddy, A.V.; Cole, M.; Price, L.; Wyllie, R.; Tasso, M.J.; Pearson, A.D. and Idle, J.R. (1996) Br. J. Clin. Pharmacol., 41(1), 13-19.
57. Chang, T.K.; Yu, L.; Maurel, P. and Waxman, D.J. (1997) Cancer Res., 57(10), 1946-1954.
58. Brain, E.G.; Yu, L.J.; Gustafsson, K.; Drewes, P. and Waxman, D.J. (1998) Br. J. Cancer, 77(11), 1768-1776.
59. Yu, L.J.; Drewes, P.; Gustafsson, K.; Brain, E.G.C.; Hecht, J.E.D. and Waxman, D.J. (1999) J. Pharmacol. Exp. Therap., 288(3), 928-937.
60. Walker, D.; Flinois, J.P.; Monkman, S.C.; Beloc, C.; Boddy, A.V.; Cholerton, S.; Daly, A.K.; Lind, M.J.; Pearson, A.D.J.; Beaune, P.H. and Idle, J.R. (1994) Biochemical Pharmacology, 47(7), 1157-1163.
61. Ren, S.; Yang, J.S.; Kalhorn, T.F. and Slattery, J.T. (1997) Cancer Res., 57(19), 4229-4235.
62. Kerbusch, T.; Mathot, R.A.; Keizer, H.J.; Kaijser, G.P.; Schellens, J.H. and Beijnen, J.H. (2001) Drug Metab. Dispos., 29(7), 967-975.
63. Mugford, C.A.; Mortillo, M.; Mico, B.A. and Tarloff, J.B. (1992) Fundam. Appl. Toxicol., 19(1), 43-49.
64. Huang, Z. and Waxman, D.J. (2001) Cancer Gene Ther., 8(6), 450-458.
65. Ross, A.D.; Varghese, G.; Oporto, B.; Carmichael, F.J. and Israel, Y. (1995) Biochem. Pharmacol., 49(7), 979-989.
66. Waxman, D.J.; Morrissey, J.J. and LeBlanc, G.A. (1989) Mol. Pharmacol., 35(4), 519-525.
67. Huang, Z.; Raychowdhury, M.K. and Waxman, D.J. (2000) Cancer Gene Ther., 7(7), 1034-1042.
68. Moore, M.J. (1991) Clin. Pharmacokinet., 20(3), 194-208.
69. LeBlanc, G.A. and Waxman, D.J. (1989) Drug Metab. Rev., 20(2-4), 395-439.
70. Relling, M.V.; Evans, R.; Dass, C.; Desiderio, D.M. and Nemec, J. (1992) J. Pharmacol. Exp. Ther., 261(2), 491-496.
71. Komatsu, T.; Yamazaki, H.; Shimada, N.; Nakajima, M. and Yokoi, T. (2000) Drug Metab. Dispos., 28(12), 1457-1463.
72. Quintieri, L.; Rosato, A.; Napoli, E.; Sola, F.; Geroni, C.; Floreani, M. and Zanovello, P. (2000) Cancer Res., 60(12), 3232-3238.
73. Ripamonti, M.; Pezzoni, G.; Pesenti, E.; Pastori, A.; Farao, M.; Bargiotti, A.; Suarato, A.; Spreafico, F. and Grandi, M. (1992) Br. J. Cancer, 65(5), 703-707.
74. Crewe, H.K.; Ellis, S.W.; Lennard, M.S. and Tucker, G.T. (1997) Biochem. Pharmacol., 53(2), 171-178.
75. Borgna, J.L. and Rochefort, H. (1981) J. Biol. Chem., 256(2), 859-868.
76. Czerwinski, M.; McLemore, T.L.; Philpot, R.M.; Nhamburo, P.T.; Korzekwa, K.; Gelboin, H.V. and Gonzalez, F.J. (1991) Cancer Res., 51(17), 4636-4638.
77. Verschoyle, R.D.; Philpot, R.M.; Wolf, C.R. and Dinsdale, D. (1993) Toxicol. Appl. Pharmacol., 123(2), 193-198.
78. Rainov, N.G.; Dobberstein, K.U.; Sena-Esteves, M.; Herrlinger, U.; Kramm, C.M.; Philpot, R.M.; Hilton, J.; Chiocca, E.A. and Breakefield, X.O. (1998) Human Gene Ther., 9(9), 1261-1273.
79. Mohr, L.; Rainov, N.G.; Mohr, U.G. and Wands, J.R. (2000) Cancer Gene Ther., 7(7), 1008-1014.
80. Frank, S.; Steffens, S.; Fischer, U.; Tlolko, A.; Rainov, N.G. and Kramm, C.M. (2002) Cancer Gene Ther., 9(2), 178-188.
81. Brown, J.M. and Giaccia, A.J. (1998) Cancer Res., 58(7), 1408-1416.
82. Boyer, M.J. (1997) Oncol. Res., 9(6-7), 391-395.
83. Brown, J.M. and Wang, L.H. (1998) Anticancer Drug Des., 13(6), 529-539.
84. Lloyd, R.V.; Duling, D.R.; Rumyantseva, G.V.; Mason, R.P. and Bridson, P.K. (1991) Mol. Pharmacol., 40(3), 440-445.
85. Hopfner, K.P.; Putnam, C.D. and Tainer, J.A. (2002) Curr. Opin. Struct. Biol., 12(1), 115-122.
86. Jounaidi, Y. and Waxman, D.J. (2000) Cancer Res., 60(14), 3761-3769.
87. Patterson, L.H.; McKeown, S.R.; Robson, T.; Gallagher, R.; Raleigh, S.M. and Orr, S. (1999) Anticancer Drug Des., 14(6), 473-486.
88. Kan, O.; Griffiths, L.; Baban, D.; Iqball, S.; Uden, M.; Spearman, H.; Slingsby, J.; Price, T.; Esapa, M.; Kingsman, S.; Kingsman, A.; Slade, A. and Naylor, S. (2001) Cancer Gene Ther., 8(7), 473-482.
89. Bunting, K.D.; Webb, M.; Giorgianni, F.; Galipeau, J.; Blakley, R.L.; Townsend, A.J. and Sorrentino, B.P. (1997) Hum. Gene Ther., 8(13), 1531-1543.
90. Morgenstern, J.P. and Land, H. (1990) Nucleic Acids Res., 18(12), 3587-3596.
91. Pear, W.S.; Nolan, G.P.; Scott, M.L. and Baltimore, D. (1993) Proc. Natl. Acad. Sci. USA, 90(18), 8392-8396.
92. Sinkovics, J. and Horvath, J. (1993) Intervirology, 36(4), 193-214.
93. Bischoff, J.R.; Kirn, D.H.; Williams, A.; Heise, C.; Horn, S.; Muna, M.; Ng, L.; Nye, J.A.; Sampson-Johannes, A.; Fattaey, A. and McCormick, F. (1996) Science, 274(5286), 373-376.
94. Heise, C.; Sampson-Johannes, A.; Williams, A.; McCormick, F.; Von Hoff, D.D. and Kirn, D.H. (1997) Nat. Med., 3(6), 639-645.
95. Yew, P.R. and Berk, A.J. (1992) Nature, 357(6373), 82-85.
96. Nemunaitis, J.; Khuri, F.; Ganly, I.; Arseneau, J.; Posner, M.; Vokes, E.; Kuhn, J.; McCarty, T.; Landers, S.; Blackburn, A.; Romel, L.; Randlev, B.; Kaye, S. and Kirn, D. (2001) J. Clin. Oncol., 19(2), 289-298.
97. Heise, C.; Lemmon, M. and Kirn, D. (2000) Clin. Cancer Res., 6(12), 4908-4914.
98. Wildner, O.; Blaese, R.M. and Morris, J.C. (1999) Cancer Res., 59(2), 410-413.
99. Wildner, O.; Morris, J.C.; Vahanian, N.N.; Ford, H., Jr.; Ramsey, W.J. and Blaese, R.M. (1999) Gene Ther., 6(1), 57-62.
100. Freytag, S.O.; Rogulski, K.R.; Paielli, D.L.; Gilbert, J.D. and Kim, J.H. (1998) Hum. Gene Ther., 9(9), 1323-1333.
101. Rogulski, K.R.; Wing, M.S.; Paielli, D.L.; Gilbert, J.D.; Kim, J.H. and Freytag, S.O. (2000) Hum. Gene Ther., 11(1), 67-76.
102. Chase, M.; Chung, R.Y. and Chiocca, E.A. (1998) Nature Biotech., 16(5), 444-448.
103. Pawlik, T.M.; Nakamura, H.; Yoon, S.S.; Mullen, J.T.; Chandrasekhar, S.; Chiocca, E.A. and Tanabe, K.K. (2000) Cancer Res., 60(11), 2790-2795.
104. Cartmell, T.; Southgate, T.; Rees, G.S.; Castro, M.G.; Lowenstein, P.R. and Luheshi, G.N. (1999) J. Neurosci., 19(4), 1517-1523.
105. Worgall, S.; Wolff, G.; Falck-Pedersen, E. and Crystal, R.G. (1997) Hum. Gene Ther., 8(1), 37-44.
106. Duncan, S.J.; Gordon, F.C.; Gregory, D.W.; McPhie, J.L.; Postlethwaite, R.; White, R. and Willcox, H.N. (1978) J. Gen. Virol., 40(1), 45-61.
107. Chen, Y.; Yu, D.C.; Charlton, D. and Henderson, D.R. (2000) Hum. Gene Ther., 11(11), 1553-1567.
108. Sullivan, D.E.; Dash, S.; Du, H.; Hiramatsu, N.; Aydin, F.; Kolls, J.; Blanchard, J.; Baskin, G. and Gerber, M.A. (1997) Hum. Gene Ther., 8(10), 1195-1206.
109. Lu, H.; Sullivan, D. and Dash, S. (2001) Zhonghua Gan Zang Bing Za Zhi., 9(5), 291-293.
110. Yu, D.C.; Chen, Y.; Seng, M.; Dilley, J. and Henderson, D.R. (1999) Cancer Res., 59(17), 4200-4203.
111. Rodriguez, R.; Schuur, E.R.; Lim, H.Y.; Henderson, G.A.; Simons, J.W. and Henderson, D.R. (1997) Cancer Res. 57(13), 2559-2563.
112. Hallenbeck, P.L.; Chang, Y.N.; Hay, C.; Golightly, D.; Stewart, D.; Lin, J.; Phipps, S. and Chiang, Y.L. (1999) Hum. Gene Ther., 10(10), 1721-1733.
113. Komata, T.; Kondo, Y.; Kanzawa, T.; Hirohata, S.; Koga, S.; Sumiyoshi, H.; Srinivasula, S.M.; Barna, B.P.; Germano, I.M.; Takakura, M.; Inoue, M.; Alnemri, E.S.; Shay, J.W.; Kyo, S. and Kondo, S. (2001) Cancer Res., 61(15), 5796-5802.
114. Dachs, G.U. and Chaplin, D.J. (1998) Semin. Radiat. Oncol., 9(3), 208-216.
115. D'Incalci, M.; Bolis, G.; Facchinetti, T.; Mangioni, C.; Morasca, L.; Morazzoni, P. and Salmona, M. (1979) Eur. J. Cancer, 15(1), 7-10.
116. Lewis, L.D.; Fitzgerald, D.L.; Harper, P.G. and Rogers, H.J. (1990) Br. J. Clin. Pharmacol., 30(5), 725-732.
117. Jounaidi, Y. and Waxman, D.J. (2001) Cancer Res., 61(11), 4437-4444.
118. Browder, T.; Butterfield, C.E.; Kraling, B.M.; Shi, B.; Marshall, B.; O'Reilly, M.S. and Folkman, J. (2000) Cancer Res., 60(7), 1878-1886.
119. Ichikawa, T.; Petros, W.P.; Ludeman, S.M.; Fangmeier, J.; Hochberg, F.H.; Colvin, O.M. and Chiocca, E.A. (2001) Cancer Res., 61(3), 864-868.
120. Anonymous (1998) Med. Lett. Drugs Ther., 40(1035), 92.
121. Huber, B.E.; Austin, E.A.; Richards, C.A.; Davis, S.T. and Good, S.S. (1994) Proc. Natl. Acad. Sci. USA, 91(17), 8302-8306.
122. Freeman, S.M.; Abboud, C.N.; Whartenby, K.A.; Packman, C.H.; Koeplin, D.S.; Moolten, F.L. and Abraham, G.N. (1993) Cancer Res., 53(21), 5274-5283.
123. Ramesh, R.; Marrogi, A.J.; Munshi, A.; Abboud, C.N. and Freeman, S.M. (1996) Exp. Hematol., 24(7), 829-838.
124. Hogquist, K.A.; Nett, M.A.; Unanue, E.R. and Chaplin, D.D. (1991) Proc. Natl. Acad. Sci. USA, 88(19), 8485-8489.
125. Gagandeep, S.; Brew, R.; Green, B.; Christmas, S.E.; Klatzmann, D.; Poston, G.J. and Kinsella, A.R. (1996) Cancer Gene Ther., 3(2), 83-88.
126. Wyllie, A.H.; Kerr, J.F. and Currie, A.R. (1980) Int. Rev. Cytol., 68, 251-306.
127. Matzinger, P. (1994) Annu. Rev. Immunol, 12, 991-1045.
128. Boyd, V.L.; Robbins, J.D.; Egan, W. and Ludeman, S.M. (1986) J. Med. Chem., 29(7), 1206-1210.
129. Hilton, J. (1984) Cancer Res., 44(11), 5156-5160.
130. Andersson, B.S.; Mroue, M.; Britten, R.A.; Farquhar, D. and Murray, D. (1995) Acta Oncol., 34(2), 247-251.
131. Tew, K.D.; Monks, A.; Barone, L.; Rosser, D.; Akerman, G.; Montali, J.A.; Wheatley, J.B. and Schmidt, D.E. Jr. (1996) Mol. Pharmacol., 50(1), 149-159.
132. Lee, F.Y. (1991) Br. J. Cancer, 63(1), 45-50.
133. Lohr, M.; Hoffmeyer, A.; Kroger, J.; Freund, M.; Hain, J.; Holle, A.; Karle, P.; Knofel, W.T.; Liebe, S.; Muller, P.; Nizze, H.; Renner, M.; Saller, R.M.; Wagner, T.; Hauenstein, K.; Gunzburg, W.H. and Salmons, B. (2001) Lancet, 357(9268), 1591-1592.
134. Hunt, S. (2001) Curr. Opin. Mol. Ther., 3(6), 595-598.